IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
182.45
-3.41 (-1.83%)
At close: Aug 1, 2025, 4:00 PM
184.77
+2.32 (1.27%)
After-hours: Aug 1, 2025, 7:16 PM EDT
Chimerix Market Cap
IQVIA Holdings has a market cap or net worth of $31.02 billion as of August 1, 2025. Its market cap has decreased by -26.08% in one year.
Market Cap
31.02B
Enterprise Value
44.57B
1-Year Change
-26.08%
Ranking
Category
Stock Price
$182.45
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from $5.46B to $31.02B, an increase of 468.31%. That is a compound annual growth rate of 15.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 31.02B | -13.04% |
| Dec 31, 2024 | 35.67B | -15.54% |
| Dec 29, 2023 | 42.23B | 10.96% |
| Dec 30, 2022 | 38.06B | -29.39% |
| Dec 31, 2021 | 53.90B | 56.91% |
| Dec 31, 2020 | 34.35B | 14.58% |
| Dec 31, 2019 | 29.98B | 27.57% |
| Dec 31, 2018 | 23.50B | 13.60% |
| Dec 29, 2017 | 20.69B | 10.50% |
| Dec 30, 2016 | 18.72B | 121.52% |
| Dec 31, 2015 | 8.45B | 12.33% |
| Dec 31, 2014 | 7.52B | 25.93% |
| Dec 31, 2013 | 5.97B | 9.47% |
| May 9, 2013 | 5.46B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.88B |
| Johnson & Johnson | 397.74B |
| AbbVie | 334.68B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 228.54B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 222.21B |
| Novo Nordisk | 213.92B |